303 related articles for article (PubMed ID: 33595192)
1. OPTN/SRTR 2019 Annual Data Report: Liver.
Kwong AJ; Kim WR; Lake JR; Smith JM; Schladt DP; Skeans MA; Noreen SM; Foutz J; Booker SE; Cafarella M; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2021 Feb; 21 Suppl 2():208-315. PubMed ID: 33595192
[TBL] [Abstract][Full Text] [Related]
2. OPTN/SRTR 2022 Annual Data Report: Liver.
Kwong AJ; Kim WR; Lake JR; Schladt DP; Schnellinger EM; Gauntt K; McDermott M; Weiss S; Handarova DK; Snyder JJ; Israni AK
Am J Transplant; 2024 Feb; 24(2S1):S176-S265. PubMed ID: 38431359
[TBL] [Abstract][Full Text] [Related]
3. OPTN/SRTR 2021 Annual Data Report: Liver.
Kwong AJ; Ebel NH; Kim WR; Lake JR; Smith JM; Schladt DP; Schnellinger EM; Handarova D; Weiss S; Cafarella M; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2023 Feb; 23(2 Suppl 1):S178-S263. PubMed ID: 37132348
[TBL] [Abstract][Full Text] [Related]
4. OPTN/SRTR 2017 Annual Data Report: Liver.
Kim WR; Lake JR; Smith JM; Schladt DP; Skeans MA; Noreen SM; Robinson AM; Miller E; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2019 Feb; 19 Suppl 2():184-283. PubMed ID: 30811890
[TBL] [Abstract][Full Text] [Related]
5. OPTN/SRTR 2018 Annual Data Report: Liver.
Kwong A; Kim WR; Lake JR; Smith JM; Schladt DP; Skeans MA; Noreen SM; Foutz J; Miller E; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2020 Jan; 20 Suppl s1():193-299. PubMed ID: 31898413
[TBL] [Abstract][Full Text] [Related]
6. OPTN/SRTR 2016 Annual Data Report: Liver.
Kim WR; Lake JR; Smith JM; Schladt DP; Skeans MA; Harper AM; Wainright JL; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2018 Jan; 18 Suppl 1():172-253. PubMed ID: 29292603
[TBL] [Abstract][Full Text] [Related]
7. OPTN/SRTR 2020 Annual Data Report: Liver.
Kwong AJ; Ebel NH; Kim WR; Lake JR; Smith JM; Schladt DP; Skeans MA; Foutz J; Gauntt K; Cafarella M; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2022 Mar; 22 Suppl 2():204-309. PubMed ID: 35266621
[TBL] [Abstract][Full Text] [Related]
8. OPTN/SRTR 2015 Annual Data Report: Liver.
Kim WR; Lake JR; Smith JM; Skeans MA; Schladt DP; Edwards EB; Harper AM; Wainright JL; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2017 Jan; 17 Suppl 1():174-251. PubMed ID: 28052604
[TBL] [Abstract][Full Text] [Related]
9. Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies.
Kling CE; Biggins SW; Bambha KM; Feld LD; Perkins JH; Reyes JD; Perkins JD
JAMA Surg; 2023 Jun; 158(6):610-616. PubMed ID: 36988928
[TBL] [Abstract][Full Text] [Related]
10. OPTN/SRTR 2020 Annual Data Report: Kidney.
Lentine KL; Smith JM; Hart A; Miller J; Skeans MA; Larkin L; Robinson A; Gauntt K; Israni AK; Hirose R; Snyder JJ
Am J Transplant; 2022 Mar; 22 Suppl 2():21-136. PubMed ID: 35266618
[TBL] [Abstract][Full Text] [Related]
11. OPTN/SRTR 2021 Annual Data Report: Kidney.
Lentine KL; Smith JM; Miller JM; Bradbrook K; Larkin L; Weiss S; Handarova DK; Temple K; Israni AK; Snyder JJ
Am J Transplant; 2023 Feb; 23(2 Suppl 1):S21-S120. PubMed ID: 37132350
[TBL] [Abstract][Full Text] [Related]
12. OPTN/SRTR 2019 Annual Data Report: Kidney.
Hart A; Lentine KL; Smith JM; Miller JM; Skeans MA; Prentice M; Robinson A; Foutz J; Booker SE; Israni AK; Hirose R; Snyder JJ
Am J Transplant; 2021 Feb; 21 Suppl 2():21-137. PubMed ID: 33595191
[TBL] [Abstract][Full Text] [Related]
13. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
[TBL] [Abstract][Full Text] [Related]
14. Liver.
Kim WR; Lake JR; Smith JM; Skeans MA; Schladt DP; Edwards EB; Harper AM; Wainright JL; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2016 Jan; 16 Suppl 2():69-98. PubMed ID: 26755264
[TBL] [Abstract][Full Text] [Related]
15. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
16. Associations Among Different Domains of Quality Among US Liver Transplant Programs.
Brown CS; Waits SA; Englesbe MJ; Sonnenday CJ; Sheetz KH
JAMA Netw Open; 2021 Aug; 4(8):e2118502. PubMed ID: 34369991
[TBL] [Abstract][Full Text] [Related]
17. Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States.
Shah RH; Chyou D; Goldberg DS
Liver Transpl; 2022 Dec; 28(12):1857-1864. PubMed ID: 35585774
[TBL] [Abstract][Full Text] [Related]
18. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35.
Nekrasov V; Matsuoka L; Rauf M; Kaur N; Cao S; Groshen S; Alexopoulos SP
Am J Transplant; 2016 Oct; 16(10):2912-2924. PubMed ID: 27063579
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses.
Wey A; Noreen S; Gentry S; Cafarella M; Trotter J; Salkowski N; Segev D; Israni A; Kasiske B; Hirose R; Snyder J
Liver Transpl; 2022 Mar; 28(3):363-375. PubMed ID: 34482614
[TBL] [Abstract][Full Text] [Related]
20. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
